Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies
Tools
Whittaker, S., Kirk, R., Hayward, R., Zambon, A., Viros, A., Cantarino, N., Affolter, A., Nourry, A., Niculescu-Duvaz, D., Springer, C., Marais, R.
(2010)
Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies.
Science Translational Medicine, 2 (35).
ISSN 1946-6234
Full text not available from this repository.
Item Type: | Article |
---|---|
Authors (ICR Faculty only): | Marais, Richard and Springer, Caroline and Niculescu-Duvaz, Dan |
All Authors: | Whittaker, S., Kirk, R., Hayward, R., Zambon, A., Viros, A., Cantarino, N., Affolter, A., Nourry, A., Niculescu-Duvaz, D., Springer, C., Marais, R. |
Additional Information: | ISI Document Delivery No.: 735OL Times Cited: 6 Cited Reference Count: 42 Whittaker, Steven Kirk, Ruth Hayward, Robert Zambon, Alfonso Viros, Amaya Cantarino, Neus Affolter, Annette Nourry, Arnaud Niculescu-Duvaz, Dan Springer, Caroline Marais, Richard Amer assoc advancement science Washington |
Uncontrolled Keywords: | randomized discontinuation trial chronic myelogenous leukemia signal-regulated kinase renal-cell carcinoma b-raf cytogenetic responses phase-ii therapeutic target tyrosine kinases oncogenic braf |
Research teams: | Closed research groups > Signal Transduction ICR divisions > Cancer Therapeutics > Gene & Oncogene Targeting |
Depositing User: | Barry Jenkins |
Date Deposited: | 05 Apr 2011 10:21 |
Last Modified: | 08 Nov 2012 15:58 |
URI: | http://publications.icr.ac.uk/id/eprint/10619 |
Actions (login required)
![]() |
View Item |